OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 70 filers reported holding OCULAR THERAPEUTIX INC in Q1 2019. The put-call ratio across all filers is 0.49 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $22,000 | -4.3% | 1,362 | -71.2% | 0.00% | -50.0% |
| Q1 2020 | $23,000 | +475.0% | 4,725 | +329.5% | 0.00% | – |
| Q4 2019 | $4,000 | +33.3% | 1,100 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | -25.0% | 1,100 | +21.1% | 0.00% | – |
| Q2 2019 | $4,000 | +33.3% | 908 | +23.7% | 0.00% | – |
| Q1 2019 | $3,000 | -62.5% | 734 | -64.5% | 0.00% | -100.0% |
| Q4 2018 | $8,000 | +100.0% | 2,069 | +240.9% | 0.00% | – |
| Q3 2018 | $4,000 | -42.9% | 607 | -19.7% | 0.00% | -100.0% |
| Q1 2017 | $7,000 | -56.2% | 756 | -60.0% | 0.00% | -50.0% |
| Q4 2016 | $16,000 | +433.3% | 1,888 | +277.6% | 0.00% | – |
| Q3 2016 | $3,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |